Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Chimera Investment CorporationNYSE: CIM
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation dips below year-ago levels
Q1 FY2026 stock-based compensation of $2.73M fell 27.2% year over year, behind the +132.1% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 85.0% from the prior quarter. Over 3 fiscal years it compounded at +90.7% a year.
Context
- Stock-based compensation amounted to 6.9% of revenue in FY2025, up 3.0 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -27.2% toward the trailing-twelve-month pace of +132.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 56.7M USD
- Year-over-year change
- +461.7%
- 4-year CAGR
- +71.8%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 56.7M | +461.7% |
| FY2024 | 2024-12-31 | 10.1M | +5.7% |
| FY2023 | 2023-12-31 | 9.55M | +16.8% |
| FY2022 | 2022-12-31 | 8.18M | +25.5% |
| FY2021 | 2021-12-31 | 6.51M | — |
Stock-Based Compensation vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's LTM Mar 2026 stock-based compensation of $25.19M is the 2nd largest of the 9 companies compared; the peer median is $1.56M.
- Its year-over-year change of +132.1% is the 2nd highest of 6, against a peer median of +2.5%.
- Stock-based compensation amounts to 4.0% of revenue for CIM, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $30M | +76.5% | +135.1% | 1.0% | |
| LTM Mar 2026 | $25.19M | +132.1% | +90.7% | 4.0% | |
| LTM Mar 2026 | $13.79M | -2.5% | -2.7% | 1.1% | |
| LTM Jun 2026 | $2.47M | +2.5% | -16.8% | 0.3% | |
| LTM Mar 2026 | $1.86M | +314.0% | -31.4% | 0.5% | |
| LTM Mar 2026 | $1.25M | -89.0% | +4.7% | 0.2% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CIM) | $1.56M | +2.5% | -2.7% | 0.2% | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 670.11M | (513.07M) | 126.1M | 176.07M | 266.42M |
| Depreciation & Amortization | 70.58M | 61.49M | 0 | 321K | 7.18M |
| Deferred Income Tax | (70.58M) | 0 | 0 | 0 | 2.27M |
| Stock-Based Compensation | 6.51M | 8.18M | 9.55M | 10.1M | 56.7M |
| Change in Working Capital | (37.57M) | (10.84M) | (30.14M) | (5.84M) | 12.04M |
| Accounts Receivables | 11.64M | 7.75M | (15.19M) | (4.43M) | 6.61M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (13.2M) | 14.89M | 292K | 13.11M | (5.61M) |
| Other Working Capital | (36.01M) | (33.48M) | (15.24M) | (14.52M) | 11.04M |
| Other Non-Cash Items | (119.87M) | 779.96M | 107.75M | 25.03M | (593.49M) |
| Operating Cash Flow | 519.18M | 325.72M | 213.27M | 205.67M | (248.88M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | (29.11M) | 0 |
| Purchases of Investments | (227.03M) | (80.93M) | 0 | 0 | 0 |
| Sales of Investments | (45.31M) | 76.47M | 0 | 0 | (23.19M) |
| Other Investing Activities | 2.82B | 514.3M | 551.75M | 207.33M | (1.63B) |
| Investing Cash Flow | 2.55B | 509.84M | 551.75M | 178.22M | (1.66B) |
| Debt Repayment | (2.36B) | (546.31M) | (598.08M) | (298.33M) | 2.32B |
| Common Stock Issued | 0 | 0 | 73.78M | 0 | 0 |
| Common Stock Repurchased | (1.83M) | (48.89M) | (33.1M) | 0 | 0 |
| Dividends Paid | (372.41M) | (361.51M) | (250.53M) | (223.25M) | (208.73M) |
| Other Financing Activities | (220.95M) | 0 | (1K) | 0 | 0 |
| Financing Cash Flow | (2.95B) | (956.7M) | (807.94M) | (521.58M) | 2.11B |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (5.88M) |
| Net Change in Cash | 116.65M | (121.14M) | (42.92M) | (137.69M) | 194.58M |
| Free Cash Flow | 519.18M | 325.72M | 213.27M | 205.67M | (248.88M) |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.